Table 2.
Characteristics of included studies
Study | Type | Setting | Patients, n | Mean age, years | Mean follow-up, years |
---|---|---|---|---|---|
de Albornoz et al34 | RCT | University | 26 | 51.7 | 1 |
Bae et al35 | Prospective | University | 19 | 47 | 1 |
Cabello et al36 | Prospective | Private | 14 | 52 | 1 |
Canullo and Götz37 | Prospective | NR | 5 | 49.1 | 1.5 |
Canullo38 | Prospective | Private | 25 | 52.28 | 3.3 |
Cionca et al39 | Prospective | University | 32 | 51.9 | 1.6 |
Cooper et al40 | Prospective | University | 41 | 30.6 | 3 |
Cosyn et al41 | Prospective | University | 25 | 54 | 3 |
den Hartog et al42 | RCT | University | 62 | 39.3 | 1.5 |
Ekfeldt et al43 | Retrospective | Private | 130 | 23 | NR |
Furze et al44 | Prospective | Private | 10 | 45.1 | 1 |
Galluci et al45 | RCT | University | 20 | NR | 2 |
Gotfredsen46 | Prospective | University | 20 | 33 | 10 |
Guljé et al47 | Prospective | Multicenter | 21 | 57 | 1 |
Hosseini et al48 | RCT | University | 36 | 28.1 | 1 |
Hosseini et al49 | Prospective | University | 59 | 27.9 | 3 |
Jemt50 | Retrospective | University | 35 | 33.5 | 10 |
Kim et al51 | Prospective | University | 213 | 56.5 | 3.6 |
Lee and Hasegawa52 | Prospective | NR | 9 | 42 | 1 |
Lops et al53 | Prospective | University | 81 | 54 | 5 |
Lops et al54 | Prospective | University | 72 | 46 | 2 |
MacDonald et al55 | Prospective | University | 20 | 43.5 | NR |
Nejatidanesh et al56 | Retrospective | University | 122 | 50 | 4.9 |
Nothdurft and Pospiech57 | Prospective | University | 24 | NR | 1 |
Passos et al58 | Retrospective | University | 141 | NR | NR |
Payer et al59 | RCT | University | 30 | NR | 2 |
Pozzi et al60 | Prospective | University | 27 | 54.18 | 3.6 |
Vanlıoglu et al61 | Prospective | University | 12 | 33.2 | 5 |
Vigolo et al62 | RCT | University | 20 | NR | 4 |
Vigolo and Givani63 | Prospective | Private | 144 | 37 | 5 |
Zembic et al64 | RCT | University | 18 | 41.6 | 5.6 |
Zembic et al65 | Prospective | University | 16 | 46 | 11.3 |
Abbreviations: RCT, randomized controlled trial; NR, not reported.